1 year evolution of COPD patients systemic endothelial dysfunction Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005
Evaluation of endothelial dysfunction at the patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 316s Year: 2004
Systemic inflammation and endothelial dysfunction in patient with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007
Systemic inflammation and vascular dysfunction in patients with OSA Source: Annual Congress 2011 - Obstructive sleep apnoea: clinical aspects I Year: 2011
Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011
Correction of endothelial dysfunction in patients with COPD, IPF Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study Source: Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment Year: 2021
Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007
Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Hypoxaemia and endothelial dysfunctional in patients with COPD Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease Year: 2009
Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004
Systemic inflammation and pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 142s Year: 2007
Determinants of endothelial function in patients with COPD Source: Eur Respir J 2013; 42: 1194-1204 Year: 2013
New markers of endothelial dysfunction in patients with COPD Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
New markers of endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 143s Year: 2007
Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008
Endothelial dysfunction as systemic effects of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 652s Year: 2006
Systemic corticosteroids and the risk of venous thromboembolism in COPD patients: A nationwide study of 30.473 outpatients with severe-very severe COPD Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021
Differences in vessel endothelium function in severe COPD and severe asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 404s Year: 2006